GGrantIndex
Sort

23,748 grants matching melanoma

Targeted Drug Delivery to Surface Receptors

$185,000
Francis C Szoka · University Of California, San Francisco · R01 · FY2009 · GM

Evolutionary trajectories of tumors following resistance to immune checkpoint blockade

$184,978
Melissa Quino Reeves · University Of Utah · R21 · FY2022 · CA

Fiberoptic Microneedle Device for Nanoparticle-Enhanced Photothermal Therapy of A

$184,970
Christopher G Rylander · Virginia Polytechnic Inst And St Univ · R21 · FY2012 · CA

Regulation of Chemokine Mediated Leukocyte Functions

$184,916
North Carolina Central University · R01 · FY2004 · AI

Design of Targeting Enhancement for Drug Delivery

$184,906
Elena Dormidontova · Case Western Reserve University · R21 · FY2006 · CA

Specification, induction and development of the neural crest in rabbit embryos

$184,815
Martin Ignacio Garcia-Castro · University Of California Riverside · R21 · FY2019 · DE

Thyroid Stimulating Hormone Promotes the Growth and Progression of Human Melanoma

$184,800
Julie A Ellerhorst · University Of Tx Md Anderson Can Ctr · R21 · FY2007 · CA

Pathways from genotype and environment to melanoma

$184,669
Nicholas K Hayward · Queensland Institute Of Medical Research · R01 · FY2011 · CA

Melanoma prevention by MC1R selective small peptide analogs of alpha MSH

$184,663
Zalfa Abdel-Malek · University Of Cincinnati · R21 · FY2016 · CA

Metabotropic Glutamate Receptor 1 in African American Prostate Cancer

$184,658
Shahriar Koochekpour · Roswell Park Cancer Institute Corp · R21 · FY2015 · CA

Ethanol-induced skin changes

$184,656
Mayumi Fujita · University Of Colorado Denver · R21 · FY2022 · AA

Investigation of autoimmune anti-retinal antibodies in diabetes

$184,656
John Heckenlively · University Of Michigan At Ann Arbor · R21 · FY2013 · EY

Inhibiting glioma dispersal using non-toxic, natural products

$184,618
John S Kuo · University Of Wisconsin-Madison · R21 · FY2013 · CA

Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis

$184,607
Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

ASYMMETRIC SYNTHESIS OF ANTITUMOR POLYKETIDES

$184,467
University Of North Carolina Chapel Hill · R01 · FY2000 · CA

Defining the Germline Genomic Landscape of a Novel GIST Multi-tumor Syndrome

$184,459
Jason Keith Sicklick · University Of California, San Diego · R21 · FY2016 · CA

Bacterial genes and promoters potential in breast cancer therapy

$184,422
Nabil Arrach · University Of California-Irvine · R21 · FY2011 · CA

Investigating Mechanisms of Hyperprogression on Anti-PD-1 Immunotherapy

$184,371
Andrew B. Sharabi · University Of California, San Diego · R21 · FY2021 · CA

PROGRAM LEADERS

$184,358
Sara A Courtneidge · Sanford Burnham Prebys Medical Discovery Institute · P30 · FY2012 · CA

NOTCH inhibition in melanoma

$184,331
Julide T Celebi · Icahn School Of Medicine At Mount Sinai · R21 · FY2015 · CA

Evaluation of TERT promoter mutations as melanoma biomarkers in tumors and plasma

$184,331
David Polsky · New York University School Of Medicine · R21 · FY2015 · CA

Uncovering the role of m6A in the melanocyte response to ultraviolet light

$184,331
Jonathan Hale Zippin · Weill Medical Coll Of Cornell Univ · R21 · FY2018 · CA

The genetic markers of ipilimumab response in patients with metastatic melanoma

$184,331
Tomas Kirchhoff · New York University School Of Medicine · R21 · FY2015 · CA

Biostatistics and Bioinformatics Core

$184,229
David P Harrington · Brigham And Women'S Hospital · P50 · FY2008 · CA

Fostering Career Development: Functional Analyses of Molecular Interactome Perturbations by Cancer Mutations

$184,179
S. Stephen Yi · University Of Texas At Austin · K22 · FY2019 · CA